| Management of patients with intrauterine fetal death. | |
| | |
MedLine Citation:
|
PMID: 9001791 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Fetal death incidence is 5-10 per 1,000 births. About 25% of the women who carry a dead fetus for more than 4 weeks will show significant alterations in their coagulation system. The treatment for a patient with endouterine fetal death depends on when the pregnancy is terminated, based on the ecographic fetus age. There were 15,070 births from January 1983 to December 1994 in Department B of the Institute of Obstetrics and Gynecology, University of Torino. We took into consideration the cases ofintrauterine fetal death between the 26th and 40th week before labour. This study is based on a cohort of 57 cases of intrauterine fetal demise from the 24th to the 40th week of pregnancy before spontaneous labour. |
| | |
Authors:
|
L Visentin; L Leo; M G Alemanno; S Arduino; R Bellino; M Tessarolo; T Wierdis; A Lanza |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical and experimental obstetrics & gynecology Volume: 23 ISSN: 0390-6663 ISO Abbreviation: Clin Exp Obstet Gynecol Publication Date: 1996 |
Date Detail:
|
Created Date: 1997-04-01 Completed Date: 1997-04-01 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7802110 Medline TA: Clin Exp Obstet Gynecol Country: ITALY |
Other Details:
|
Languages: eng Pagination: 263-7 Citation Subset: IM |
Affiliation:
|
Dept. B of Gynecology, University of Totino, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortion, Therapeutic*
/
methods Cesarean Section Dilatation and Curettage Female Fetal Death* Humans Labor, Induced / methods Pregnancy Pregnancy Trimester, Second Pregnancy Trimester, Third |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cervical cerclage in the treatment of cervical incompetence in Zambian women.
Next Document: DNA testing in familial hypertrophic cardiomyopathy: clinical and laboratory implications.